162 related articles for article (PubMed ID: 34703741)
1. Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis.
Furino C; Niro A; Sborgia L; Reibaldi M; Boscia F; Alessio G
Taiwan J Ophthalmol; 2021; 11(3):259-265. PubMed ID: 34703741
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.
Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C
Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387
[TBL] [Abstract][Full Text] [Related]
3. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
[TBL] [Abstract][Full Text] [Related]
4. Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction.
Rossi S; Testa F; Melillo P; Orrico A; Della Corte M; Simonelli F
BMC Ophthalmol; 2016 Jul; 16():110. PubMed ID: 27430356
[TBL] [Abstract][Full Text] [Related]
5. Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study.
Chatziralli IP; Theodossiadis GP; Parikakis E; Datseris I; Theodossiadis P
Cutan Ocul Toxicol; 2016 Dec; 35(4):263-9. PubMed ID: 26555379
[TBL] [Abstract][Full Text] [Related]
6. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
[TBL] [Abstract][Full Text] [Related]
7. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
[TBL] [Abstract][Full Text] [Related]
8. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis.
Thomas AS; Folgar FA; Jaffe GJ; Toth CA; Mahmoud TH
Ophthalmol Retina; 2019 Jan; 3(1):42-52. PubMed ID: 30929816
[TBL] [Abstract][Full Text] [Related]
9. Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.
Zandi S; Freiberg F; Vaclavik V; Pfister IB; Traine PG; Kaya C; Michels S; Garweg JG
J Ocul Pharmacol Ther; 2020 Mar; 36(2):126-132. PubMed ID: 31934816
[No Abstract] [Full Text] [Related]
10. ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.
Tadayoni R; Holz FG; Zech C; Liu X; Spera C; Stalmans P
Retina; 2019 Dec; 39(12):2341-2352. PubMed ID: 30308558
[TBL] [Abstract][Full Text] [Related]
11. LONGITUDINAL MICROPERIMETRY EVALUATION AFTER INTRAVITREAL OCRIPLASMIN INJECTION FOR VITREOMACULAR TRACTION.
Cacciamani A; Gelso A; Simonett JM; Ripandelli G; Pileri M; Stirpe M; Scarinci F
Retina; 2017 Oct; 37(10):1832-1838. PubMed ID: 28033236
[TBL] [Abstract][Full Text] [Related]
12. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
[TBL] [Abstract][Full Text] [Related]
13. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].
Maier M; Abraham S; Frank C; Lohmann CP; Feucht N
Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial.
Lavine JA; Srivastava SK; Dukles N; Reese JL; Ehlers JP
Br J Ophthalmol; 2020 Mar; 104(3):410-415. PubMed ID: 31248879
[TBL] [Abstract][Full Text] [Related]
15. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report.
Katsanos A; Gorgoli K; Asproudis I; Stefaniotou M
Ophthalmol Ther; 2021 Mar; 10(1):187-192. PubMed ID: 33108639
[TBL] [Abstract][Full Text] [Related]
17. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study.
Greven MA; Garg S; Chiu B; Shah SP; Wolfe J; Fine HF; Roth DB; Robinson J; Mong J; Hsu J; Regillo C; Ho A; Haller JA
Br J Ophthalmol; 2016 Sep; 100(9):1211-5. PubMed ID: 26659344
[TBL] [Abstract][Full Text] [Related]
18. Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion: Results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials.
Varma R; Haller JA; Kaiser PK
JAMA Ophthalmol; 2015 Sep; 133(9):997-1004. PubMed ID: 26068086
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance.
Muqit MMK; Hamilton R; Ho J; Tucker S; Buck H
PLoS One; 2018; 13(5):e0197072. PubMed ID: 29768451
[TBL] [Abstract][Full Text] [Related]
20. COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMY.
Scholz P; Sitnilska V; Hess J; Becker M; Michels S; Fauser S
Retina; 2019 Jan; 39(1):180-185. PubMed ID: 29135889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
